SUISPIRIN, 1000 MG/G, ORAL POWDER FOR PIGS
Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Toote omadused
(SPC)
31-05-2016
Mõned selle toote dokumendid pole praegu saadaval. Võite saata päringu meie klienditeenindusele ja me teavitame teid sellest niipea, kui meil on neid võimalik hankida.
Saada päring.
Saada päring.
Toimeaine:
ACETYLSALICYLIC ACID
Saadav alates:
aniMedica GmbH
ATC kood:
QN02BA01
INN (Rahvusvaheline Nimetus):
ACETYLSALICYLIC ACID
Annus:
1000 mg/g
Ravimvorm:
Oral Powder
Retsepti tüüp:
POM
Terapeutiline rühm:
Porcine
Terapeutiline ala:
Acetylsalicylic acid
Näidustused:
Miscellaneous
Volitamisolek:
Authorised
Loa andmise kuupäev:
2011-10-28
Toote omadused
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Suispirin, 1000 mg/g, oral powder for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1.0 g powder contains:
ACTIVE SUBSTANCE:
Acetylsalicylic acid
1000
mg
3 PHARMACEUTICAL FORM
Oral powder.
White to almost white powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pig:
Supportive treatment for reduction of pyrexia in combination with, appropriate anti-infective therapy, if necessary.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or in cases of gastrointestinal
irritation and ulcers, chronic gastro-intestinal disorders, bronchospasm, liver function impairment or nephropathies.
Do not use in pregnant or lactating sows.
Do not use in piglets less than 4 weeks of age.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In combined treatment with tetracyclines, a treatment interval of at least one hour between the two active agents is
recommended.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/05/2016_
_CRN 7023232_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
It must be ensured that the animals consume sufficient water during treatment.
Given that Suispirin may inhibit clotting of blood, it is recommended that elective surgery should not be performed on
animals within 7 days after the end of treatment.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Do not eat, drink or smoke whilst using this product. Contact via the skin or mucous membranes of the user must be
avoided due to the risk of sensitisation. If you know t
Lugege kogu dokumenti
